Foreword
Towards Equity in Women’s Health: Bridging Promises,
Action, and Progress
Heling Bao1; Linhong Wang2,3,#
Women’s health equity refers to the equitable achievement of optimal health outcomes for all women, irrespective
of gender, socioeconomic status, race, geographic location, or other social determinants of health. This concept
emphasizes dismantling systemic barriers and customizing interventions to address the diverse needs of women
throughout their life course (1). Bridging women’s health disparities yields substantial economic and societal
benefits. The World Health Organization (WHO) estimates that eliminating gender health gaps could contribute
12 trillion US dollars (USD) to the global economy by 2040 (2). Globally, progress remains uneven. While high-
income countries have made significant advances in reducing maternal mortality, profound disparities persist in low-
resource settings. Moreover, challenges endure even in developed regions, where socioeconomically disadvantaged
populations experience disproportionately higher rates of preventable diseases such as cervical cancer (3). Current
impediments include fragmented health policies, inadequate funding for gender-specific research, and cultural
stigmas that restrict healthcare access. For instance, merely 5% of global health research addresses conditions specific
to women (4), perpetuating critical gaps in evidence-based care. The World Economic Forum 2024 identifies nine
key health conditions that collectively account for one-third of the women’s health gap: breast cancer, cervical
cancer, menopause, endometriosis, premenstrual syndrome, postpartum hemorrhage, maternal hypertensive
disorders, migraine, and ischemic heart disease (5). Addressing these disparities necessitates progressing beyond
universal commitments to implementing targeted interventions that address inequities in treatment approaches, care
delivery systems, data collection, and funding allocation — a central theme in advancing women’s health equity.
This special issue comprises five pivotal studies addressing the three leading contributors to the global women’s
health gap: breast cancer, cervical cancer, and menopausal syndrome. Breast cancer remains the predominant cause
of cancer-related mortality among women, while cervical cancer — though highly preventable — continues to claim
numerous lives due to inequitable access to vaccines and screening services. Menopause, despite being a natural
physiological transition, receives inadequate attention in health systems worldwide, despite its profound impact on
women’s physical and mental well-being (6). For cervical cancer elimination, Zhang et al. estimated cervical cancer
screening rates based on national surveillance data, revealing persistent coverage disparities, particularly in rural and
resource-limited settings (7), while Gao et al. assessed human papillomavirus (HPV) infection severity and cervical
lesion prevalence utilizing screening data from 23 provincial-level administrative divisions (PLADs) (8). Together,
these investigations provide actionable evidence to accelerate China’s cervical cancer elimination strategy. Bao et al.
examined the relationship between socioeconomic status (SES) and breast cancer incidence through cohort analysis,
underscoring the necessity for SES-stratified prevention approaches (9). Complementing this research, Liu et al.
analyzed breast nodule detection rates using healthcare big data across 31 PLADs in China, advocating for risk-
tailored screening programs that prioritize high-burden regions (10). Finally, Yong et al. investigated the prevalence
and severity of menopausal symptoms in women aged 40–60, challenging the long-standing neglect of post-
reproductive health in policy agendas (11). Collectively, these studies illuminate critical pathways to close the
women’s health gap: from SES-informed cancer prevention strategies to equitable screening expansion and
comprehensive life-course care. By translating robust evidence into targeted interventions, we advance toward
bridging promises with measurable progress.
China has made significant strides in narrowing women’s health disparities through initiatives including
substantial reductions in maternal and infant mortality rates, implementation of nationwide breast and cervical
cancer screening programs, and the recent incorporation of adolescent health and menopause management into
national women’s health guidelines. However, substantial challenges persist: pronounced gender and urban-rural
disparities in vulnerability and healthcare access remain evident, while systemic barriers — including fragmented
health financing mechanisms and insufficient prioritization of women’s health issues — continue to undermine
China CDC Weekly
Copyright © 2025 by Chinese Center for Disease Control and Prevention CCDC Weekly / Vol. 7 / No. 10 319
equity goals. Additionally, women’s health equity represents not merely a healthcare concern but also an economic
and workforce imperative. To accelerate progress, six strategic priorities warrant immediate attention. First,
enhancing comprehensive data collection systems to capture the nuanced needs of diverse female populations is
essential. Second, expanding support for basic science and clinical research focused on women-specific conditions is
critical to address persistent gaps in evidence-based care. Third, developing sex-based healthcare delivery systems will
ensure more tailored and effective services across the lifespan. Fourth, implementing accessible solutions can
effectively bridge geographic and socioeconomic barriers to care. Fifth, directing substantial resources into women’s
health fields will create sustainable infrastructure to support these comprehensive efforts. Finally, ensuring workplace
accommodations for pregnant, postpartum, and menopausal women is vital to promote long-term well-being and
productivity. By prioritizing these strategic actions, China can establish global leadership in addressing the women’s
health gap.
doi: 10.46234/ccdcw2025.051
# Corresponding author: Linhong Wang,
[email protected].
1 Institute of Medical Information, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; 2 National Center for
Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; 3 Chinese
Association of Women and Child Health Studies, Beijing, China.
Copyright © 2025 by Chinese Center for Disease Control and Prevention. All content is distributed under a Creative Commons Attribution Non
Commercial License 4.0 (CC BY-NC).
Submitted: February 17, 2025
Accepted: February 26, 2025
Issued: March 07, 2025
REFERENCES
World Health Organization. Health equity. 2025. https://www.who.int/health-topics/health-equity#tab=tab_1. [2025-2-15].1.
McKinsey Global Institute. COVID-19 and gender equality: countering the regressive effects. 2020. https://www.mckinsey.com/featured-insights/future-
of-work/covid-19-and-gender-equality-countering-the-regressive-effects. [2025-2-15].
2.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a
baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health 2023;11(2):e197 − 206. https://doi.org/10.1016/S2214-
109X(22)00501-0.
3.
Funding research on women’s health. Nat Rev Bioeng 2024;2(10):797-8. http://dx.doi.org/10.1038/s44222-024-00253-7.4.
World Economic Forum. Blueprint to close the women’s health gap: how to improve lives and economies for all. 2025. https://reports.weforum.org/docs/
WEF_Blueprint_to_Close_the_Women%E2%80%99s_Health_Gap_2025.pdf. [2024-2-15].
5.
El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, et al. The menopause transition and women’s health at midlife: a
progress report from the Study of Women’s Health Across the Nation (SWAN). Menopause 2019;26(10):1213 − 27. https://doi.org/10.1097/GME.
0000000000001424.
6.
Zhang M, Wang LM, Zhang X, Li C, Zhao ZP, Yu MT, et al. Cervical cancer screening rates among Chinese women — China, 2023–2024. China CDC
Wkly 2025;7(10):321-6. https://doi.org/10.46234/ccdcw2025.052.
7.
Gao D, Zhao GL, Wang XY, Juan J, Shi YP, Xu TY, et al. Association between high-risk human papillomavirus infection and cervical cytology in health
check-up women — 23 PLADs, China, 2023. China CDC Wkly 2025;7(10):327-33. https://doi.org/10.46234/ccdcw2025.053.
8.
Bao HL, Fang LW, Cong S, Guo XL, Fu ZT, Liu XL, et al. Female breast cancer incidence and association with individual-level socioeconomic status in a
population-based cohort, China, 2018–2024. China CDC Wkly 2025;7(10):341-6. https://doi.org/10.46234/ccdcw2025.055.
9.
Liu, XX, Xing YX, Zu YN, Bao HL, Ding X, Chen YC, et al. Detection and BI-RADS classification of female breast nodules, China, 2021. China CDC
Wkly 2025;7(10):347-52. https://doi.org/10.46234/ccdcw2025.056.
10.
Yong ZH; Yang YH; Yang YL; Yang L; Zhao YX; Luo XM, et al. Prevalence and severity of menopausal symptoms in women of different ages — China,
2023–2024. China CDC Wkly 2025;7(10):334-40. https://doi.org/10.46234/ccdcw2025.054.
11.
Linhong Wang
Professor and Chief Expert of the National Center for Chronic and Noncommunicable
Disease Control and Prevention, China CDC, Beijing, China
Chinese Association of Women and Child Health Studies, Beijing, China
China CDC Weekly
320 CCDC Weekly / Vol. 7 / No. 10 Chinese Center for Disease Control and Prevention
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.